Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$192M |
| 2 |
Johnson & Johnson
JNJ
|
+$179M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$177M |
| 4 |
Chubb
CB
|
+$153M |
| 5 |
Eli Lilly
LLY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
+$186M |
| 3 |
Comcast
CMCSA
|
+$179M |
| 4 |
Pfizer
PFE
|
+$168M |
| 5 |
Gilead Sciences
GILD
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.85% |
| 2 | Technology | 12.31% |
| 3 | Financials | 12.27% |
| 4 | Industrials | 10.64% |
| 5 | Consumer Staples | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NMRX
2451
DELISTED
Numerex Corp
NMRX
| $1.31M | ﹤0.01% |
215,100
+30,800
| +17% | +$183K |
|
|
NTK
2452
DELISTED
NORTEK INC COM NEW (DE)
NTK
| $1.31M | ﹤0.01% |
27,100
-15,400
| -36% | -$629K |
|
|
FRBK
2453
DELISTED
Republic First Bancorp Inc
FRBK
| $1.31M | ﹤0.01% |
310,800
-8,640
| -3% | -$35.8K |
|
|
VSLR
2454
DELISTED
VIVINT SOLAR, INC.
VSLR
| $1.31M | ﹤0.01% |
+493,455
| New | +$3.18M |
|
|
SRGA
2455
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $1.31M | ﹤0.01% |
10,890
+2,317
| +27% | +$243K |
|
2456
Ardmore Shipping
ASC
$719M
| $1.31M | ﹤0.01% |
154,500
-53,300
| -26% | -$476K |
|
2457
Xencor
XNCR
$1.7B
| $1.3M | ﹤0.01% |
+97,100
| New | +$1.15M |
|
2458
FTAI Aviation
FTAI
$22.3B
| $1.3M | ﹤0.01% |
+153,284
| New | +$1.29M |
|
2459
Cytokinetics
CYTK
$10.2B
| $1.3M | ﹤0.01% |
184,479
-334,799
| -64% | -$2.45M |
|
2460
Chicago Rivet & Machine Co
CVR
$9.92M
| $1.3M | ﹤0.01% |
53,100
+400
| +0.8% | +$9.67K |
|
|
SPAN
2461
DELISTED
Span-America Medical Systems I
SPAN
| $1.3M | ﹤0.01% |
68,300
+1,900
| +3% | +$36.2K |
|
|
MEET
2462
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $1.29M | ﹤0.01% |
455,567
+184,719
| +68% | +$584K |
|
2463
VanEck Oil Services ETF
OIH
$2.01B
| $1.29M | ﹤0.01% |
+2,425
| New | +$1.19M |
|
|
MCF
2464
DELISTED
Contango Oil & Gas Co.
MCF
| $1.29M | ﹤0.01% |
109,400
+15,336
| +16% | +$106K |
|
2465
Jabil
JBL
$38B
| $1.28M | ﹤0.01% |
66,700
-1,174,700
| -95% | -$23.7M |
|
|
APLP
2466
DELISTED
Archrock Partners, L.P. Common Units representing Limited Partner Interests
APLP
| $1.28M | ﹤0.01% |
115,800
-100,892
| -47% | -$882K |
|
2467
Acco Brands
ACCO
$399M
| $1.28M | ﹤0.01% |
142,447
-85,283
| -37% | -$596K |
|
|
MINI
2468
DELISTED
Mobile Mini Inc
MINI
| $1.27M | ﹤0.01% |
+38,570
| New | +$1.09M |
|
|
AVX
2469
DELISTED
AVX Corporation
AVX
| $1.27M | ﹤0.01% |
101,300
+48,131
| +91% | +$560K |
|
2470
Ingles Markets
IMKTA
$1.67B
| $1.27M | ﹤0.01% |
33,874
-8,600
| -20% | -$308K |
|
2471
Twin Disc
TWIN
$351M
| $1.26M | ﹤0.01% |
124,700
+1,599
| +1% | +$15.4K |
|
|
SFE
2472
DELISTED
Safeguard Scientifics, Inc.
SFE
| $1.26M | ﹤0.01% |
94,800
+64,800
| +216% | +$815K |
|
2473
Enovis
ENOV
$1.52B
| $1.25M | ﹤0.01% |
25,506
-69,952
| -73% | -$2.98M |
|
|
ATE
2474
DELISTED
Advantest Corp
ATE
| $1.25M | ﹤0.01% |
135,000
+26,900
| +25% | +$241K |
|
|
WEB
2475
DELISTED
Web.com Group, Inc.
WEB
| $1.25M | ﹤0.01% |
63,000
-375,000
| -86% | -$6.86M |
|
Similar funds
Jim Simons's Q1 2016 Portfolio in Review
As of Q1 2016, Jim Simons held 3,753 positions worth $52.6B, up 15% from $45.9B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.31B of net new capital in Q1 2016, opening 498 new positions and adding to 2,018 existing holdings. Its largest new stake was EMC CORPORATION: 7,000,400 shares worth $187M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $168M trimmed.
- Jim Simons's largest Q1 2016 buy was EMC CORPORATION: 7,000,400 shares worth $187M.
- Jim Simons added most to PepsiCo in Q1 2016, an estimated $192M increase.
- Jim Simons's biggest Q1 2016 reduction was Pfizer, cutting an estimated $168M.
- Jim Simons fully exited Apple in Q1 2016, selling an estimated $470M.
- Jim Simons's ten largest holdings make up 7.9% of its $52.6B portfolio in Q1 2016.
- Jim Simons opened 498 new positions and closed 403 in Q1 2016.
- Jim Simons's portfolio value rose 15% quarter-over-quarter to $52.6B.
Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.